Price to Book Value Chart

View Price to Book Value for OCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2023. Start Trial.
Date Value
August 24, 2026 2.992
August 21, 2026 2.971
August 20, 2026 2.983
August 19, 2026 3.081
August 18, 2026 2.994
August 17, 2026 2.983
August 14, 2026 2.938
August 13, 2026 2.910
August 12, 2026 2.926
August 11, 2026 2.895
August 10, 2026 2.897
August 07, 2026 2.879
August 06, 2026 2.811
August 05, 2026 2.740
August 04, 2026 2.722
August 03, 2026 2.699
July 31, 2026 2.568
July 30, 2026 2.545
July 29, 2026 2.461
July 28, 2026 2.510
July 27, 2026 2.502
July 24, 2026 2.527
July 23, 2026 2.597
July 22, 2026 2.595
July 21, 2026 2.715
Date Value
July 20, 2026 2.663
July 17, 2026 2.768
July 16, 2026 2.863
July 15, 2026 2.979
July 14, 2026 2.936
July 13, 2026 2.985
July 10, 2026 3.094
July 09, 2026 3.110
July 08, 2026 3.110
July 07, 2026 3.078
July 06, 2026 3.133
July 02, 2026 3.206
July 01, 2026 3.072
June 30, 2026 3.149
June 29, 2026 3.230
June 26, 2026 2.961
June 25, 2026 2.897
June 24, 2026 2.852
June 23, 2026 2.892
June 22, 2026 2.880
June 18, 2026 2.769
June 17, 2026 2.788
June 16, 2026 2.825
June 15, 2026 2.865
June 12, 2026 2.737

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novartis AG 7.050
Roche Holding AG --
Addex Therapeutics Ltd. 0.9122
Sandoz Group AG --
Galderma Group AG --

Price to Book Value Related Metrics

Price 12.94
Earnings Yield -13.59%
Market Cap 799.12M